The associate professor from The University of Texas MD Anderson Cancer Center discussed eligibility for autologous stem cell transplant in patients with multiple myeloma.
Elisabet E. Manasanch, MD
Advertisement
Associate professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Articles by Elisabet E. Manasanch, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
2
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
3
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
4
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
5
